Herbal capsule for recent ischemic stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a Chinese herbal capsule (Getong Tongluo) can improve recovery after a recent ischemic stroke. It may help reduce disability by protecting brain cells and improving blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had an ischemic stroke within the last 21 days.
- Before the stroke, you were able to live independently.
- You do not have severe heart, liver, or kidney disease, cancer, or recent heart attack.
- You are not allergic to kudzu root or similar herbs.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a traditional Chinese medicine (herbal) treatment for people who have had a recent acute ischemic stroke. It will see if the herbal medicine helps improve recovery and how it works in the body, potentially offering a new treatment option.
This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.
This trial tests a Chinese herbal prescription to see if it can help repair blood vessels and improve fat processing in people who had a stroke about a month ago. It may help with recovery and prevent further heart or brain issues.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This trial tests a Chinese herbal capsule called Fufang Congrong Yizhi Capsule (FCYC) to see if it can help with memory and thinking problems that start after a bleeding stroke. It is for people who have had robot-assisted surgery for their stroke and also fit a specific pattern in traditional Chinese medicine.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
Hear when a new Ischemic Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.